Evidence map›Paper›PMID 37085781›Full record

Observational studyBMC pediatrics2023

Multicolored MIS-C, a single-centre cohort study.

Petra Varga, András Balajthy, Erika Biró, Bernadett Bíró, Zsolt Reiger, Edit Szikszay, Gábor Mogyorósy, Rita Káposzta, Tamás Szabó

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Petra VargaDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary.
András BalajthyDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary.
Erika BiróDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary.
Bernadett BíróDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary.
Zsolt ReigerDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary.
Edit SzikszayDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary.
Gábor MogyorósyDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary.
Rita KáposztaDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary.
Tamás SzabóDepartment of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei krt 98, 4032, Debrecen, Hungary. szabotamas@med.unideb.hu.
University of Debrecen · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to investigate the clinical and laboratory parameters that can predict the severity of Multisystem Inflammatory Syndrome in Children (MIS-C) at admission.

methodsWe conducted a single-center, partly retrospective, partly prospective, observational cohort study between November 1, 2020 and December 31, 2021, which included patients aged from 1 month to 19 years, meeting the diagnostic criteria of MIS-C. We categorized the patients into three subgroups based on clinical and laboratory markers and assessed the predictive value of these factors in terms of ICU administration and cardiac abnormalities.

results53 patients were classified in the following subgroups: Kawasaki-like disease (group 1) (47.2%, n = 25), shock with or without acute cardiac dysfunction (group 2) (32%, n = 17), fever and inflammation (group 3) (20.8%, n = 11). Subgroup analysis revealed that patients with shock and KD at initial presentation had significantly more severe manifestation of MIS-C requiring intensive care unit (ICU) treatment. Of the initial laboratory values, only CRP showed a significant difference between the 3 clinical groups, being lower in group 3. 52.6% of patients were admitted to the ICU. The median length of ICU stay was 3 days (range 3-20). ICU admission was more likely in patients with shortness of breath, renal failure (AKI) and patients with significantly increased concentrations of ferritin, D-dimer, INR and significantly milder increase concentration of fibrinogen. We found that fibrinogen and ferritin levels are independent risk factors for ICU admission. Cardiac abnormalities were found in 56.6% of total (30/53), with the following findings: decreased left ventricular function (32%), coronary abnormality (11.3%), pericardial effusion (17%), arrhythmia (32.1%) and mitral regurgitation (26.6%). Diarrhea and conjunctivitis at the initial presentation with significantly elevated CRP, Pro-BNP and blood pH concentrations were found to be a potential predisposing factor for decreased cardiac function while Pro-BNP and pH were independent risk factors for MIS-C. Regardless of the initial symptoms of MIS-C, the outcome was generally favorable.

conclusionsClinical characteristics and baseline laboratory values ​​may help identify patients at increased risk for severe disease outcome, such as need for intensive care, presence of shock and decreased cardiac function.

trial registrationParticipation consent was not reqired and ethical considerations were unnecessary, since we did not perform any extra interventions, only the necessary and usual therapeutic and diagnostic methods were used.

Indexed as

SARS-CoV-2Systemic Inflammatory Response SyndromeChildCohort StudiesCOVID-19FibrinogenHumansProspective StudiesRetrospective StudiesFibrinogenCOVID-19 in childrenMIS-CMultisystem inflammatory syndrome in childrenSARS-CoV-2

Identifiers

PMID37085781
PMCPMC10119512
OpenAlexW4366688351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.